Pegylated interferon-alpha2/ribavirin (peg-IFN/RBV) is the standard of care (SOC) for patients with chronic hepatitis C (CHC) infection. Currently, direct-acting antiviral agents (DAAs) are evaluated in clinical trials. The aim of this study was to compare baseline characteristics and sustained viro
Treatment of chronic hepatitis C in Europe
โ Scribed by Colombo, Massimo ;Rumi, Maria Grazia ;Ninno, Ersilio Del
- Book ID
- 106177999
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 48 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Our algorithm cannot be directly applied to other populations directly because clinical backgrounds differ among countries. However, we think that our study is applicable on a global scale because it has clearly shown that a combination of viral and host factors is effective for predicting the respo
Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the d